Accept Refuse

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 52019M9540

Prior notification of a concentration (Case M.9540 — Permira/Cambrex) Candidate case for simplified procedure (Text with EEA relevance)2019/C 379/06

PUB/2019/93

OJ C 379, 8.11.2019, p. 7–7 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

8.11.2019   

EN

Official Journal of the European Union

C 379/7


Prior notification of a concentration

(Case M.9540 — Permira/Cambrex)

Candidate case for simplified procedure

(Text with EEA relevance)

(2019/C 379/06)

1.   

On 4 November 2019, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

Permira Holdings Limited (United Kingdom), and

Cambrex Corporation (United States of America).

Permira Holdings Limited acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Cambrex Corporation.

The concentration is accomplished by way of purchase of shares.

2.   

The business activities of the undertakings concerned are:

for Permira Holdings Limited: long-term private equity investments in companies active in a wide variety of sectors, including in the area of pharmaceutical contract development and manufacturing where Permira controls two companies, Lyophilization Services of New England (LSNE) and Quotient Sciences,

for Cambrex Corporation: pharmaceutical contract development and manufacturing providing drug substance, drug product, and analytical services.

3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.   

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9540 — Permira/Cambrex

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË


(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.


Top